Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Novel N-p-methylphenyl-benzamide estrogen-related receptor activity regulating compound and medical application thereof

A compound, estrogen technology, applied in organic chemistry, amide active ingredient, drug combination, etc.

Inactive Publication Date: 2017-03-29
QILU UNIV OF TECH
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

These studies suggest that modulators targeting ERRα have the potential to serve as clinically effective antitumor agents

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel N-p-methylphenyl-benzamide estrogen-related receptor activity regulating compound and medical application thereof
  • Novel N-p-methylphenyl-benzamide estrogen-related receptor activity regulating compound and medical application thereof
  • Novel N-p-methylphenyl-benzamide estrogen-related receptor activity regulating compound and medical application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0014] The present invention is described in detail and specifically by specific examples below, to better understand the present invention, but following examples do not limit the scope of the present invention, below will describe in detail the biological activity and pharmacological evaluation of formula I compound of the present invention .

[0015] Embodiment 1 Use reporter gene to test the transcriptional regulation activity of formula I compound to ERR-alpha

[0016]

[0017] This example illustrates that the compound of formula I involved in the present invention can effectively inhibit the expression of the reporter gene regulated by ERR-alpha in human embryonic kidney cells HEK-293, indicating that the compound of formula I involved in the present invention can effectively regulate ERR-alpha alpha function. Reporter gene testing techniques are familiar to those skilled in the art.

[0018] We used the GAL4 fusion receptor activation method to test the transcript...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a novel N-p-methylphenyl-benzamide estrogen-related receptor activity regulating compound with a formula I, pharmaceutically acceptable salt of the compound and an application of the compound. The compound and the pharmaceutically acceptable salt thereof can be used for preparing a medicine with the functions of regulating ERR-alpha (estrogen-related receptor alpha) or ERR alpha activity and preventing and treating malignant tumors such as breast cancer, prostatic cancer, stomach cancer, colon cancer, ovarian cancer and cervical cancer).

Description

technical field [0001] The present invention relates to a novel N-p-tolyl-benzamide compound and its pharmaceutically acceptable salt as a method for regulating estrogen-related receptor alpha (ERR-alpha or ERRα). Agents and their drug combinations and their use in the preparation of drugs for the prevention and / or treatment of tumors such as breast cancer, prostate cancer, gastric cancer, colon cancer, ovarian cancer, cervical cancer or endometrial cancer. Background technique [0002] ERRα was cloned and identified by Giguere et al. in 1988. As an orphan nuclear receptor (Orphan nuclear receptor), the endogenous ligand of ERRα has not been discovered. ERRα is widely expressed in the body and can be detected from myocardium, digestive tract, brain, skeletal muscle, brown fat, breast cancer, ovarian cancer and other malignant tumors. ERRα has high homology with estrogen receptor α (ERα): DNA binding domain (DNA binding domain, DBD) amino acid similarity is 68%, and ligand ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07C311/08A61K31/18A61P35/00
CPCC07C311/08
Inventor 杜永丽关海星凌浩李群益
Owner QILU UNIV OF TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com